Apexbio Technology LLC Ticlopidine HCl 53885-35-1 1g

Supplier:  Apexbio Technology LLC B21641000

Ticlopidine HCl is a small-molecule inhibitor targeting the platelet P2Y purinergic receptor subtype It is designed to inhibit platelet aggregation by blocking the interaction of extracellular adenosine diphosphate (ADP) with its receptor thereby suppressing ADP-induced signaling pathways essential for platelet activation Ticlopidine HCl exerts its biological activity primarily through selective inhibition of ADP-driven platelet responses It demonstrates inhibitory activity with an IC50 of approximately 2 M Based on these pharmacological properties Ticlopidine HCl holds research potential in studies of platelet activation mechanisms thrombotic disease modeling and evaluation of therapeutic approaches targeting ADP-mediated platelet signaling pathways

Catalog No. 50-000-89399